Johnson & Johnson Pre-Tax Income 2010-2024 | JNJ

Johnson & Johnson pre-tax income for the twelve months ending September 30, 2024 was $17.626B, a 38.56% increase year-over-year.

  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.
  • Johnson & Johnson annual pre-tax income for 2022 was $19.359B, a 0.94% increase from 2021.
  • Johnson & Johnson annual pre-tax income for 2021 was $19.178B, a 16.25% increase from 2020.

Johnson & Johnson Pre-Tax Income 2010-2024 | JNJ

  • Johnson & Johnson annual pre-tax income for 2023 was $15.062B, a 22.2% decline from 2022.
  • Johnson & Johnson annual pre-tax income for 2022 was $19.359B, a 0.94% increase from 2021.
  • Johnson & Johnson annual pre-tax income for 2021 was $19.178B, a 16.25% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B